116 related articles for article (PubMed ID: 17826442)
1. Comment on single-dose methotrexate regimen in the treatment of low-risk gestational trophoblastic neoplasia.
Mahajan NN; Soni RN; Mahajan KN
Am J Obstet Gynecol; 2007 Sep; 197(3):325; author reply 325. PubMed ID: 17826442
[No Abstract] [Full Text] [Related]
2. Single-dose methotrexate regimen in the treatment of low-risk gestational trophoblastic neoplasia.
Chan KK; Huang Y; Tam KF; Tse KY; Ngan HY
Am J Obstet Gynecol; 2006 Nov; 195(5):1282-6. PubMed ID: 16723109
[TBL] [Abstract][Full Text] [Related]
3. Weekly methotrexate (50mg/m(2)) without dose escalation as a primary regimen for low-risk gestational trophoblastic neoplasia.
Kang WD; Choi HS; Kim SM
Gynecol Oncol; 2010 Jun; 117(3):477-80. PubMed ID: 20347479
[TBL] [Abstract][Full Text] [Related]
4. Low-risk gestational trophoblastic neoplasia: evaluating the need for initial inpatient treatment during low-dose methotrexate chemotherapy.
Carter LD; Hancock BW; Everard JE
J Reprod Med; 2008 Jul; 53(7):525-7. PubMed ID: 18720928
[TBL] [Abstract][Full Text] [Related]
5. [Single methotrexate chemotherapy for low-risk gestational trophoblastic tumor].
Lu WG; Ding ZM; Xie X; Ye DF; Chen HZ; Feng SW
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Aug; 25(4):414-7. PubMed ID: 12974085
[TBL] [Abstract][Full Text] [Related]
6. Treatment of low-risk gestational trophoblastic neoplasia.
Aghajanian C
J Clin Oncol; 2011 Mar; 29(7):786-8. PubMed ID: 21263092
[No Abstract] [Full Text] [Related]
7. Methotrexate for 2000 FIGO low-risk gestational trophoblastic neoplasia patients: efficacy and toxicity.
Chalouhi GE; Golfier F; Soignon P; Massardier J; Guastalla JP; Trillet-Lenoir V; Schott AM; Raudrant D
Am J Obstet Gynecol; 2009 Jun; 200(6):643.e1-6. PubMed ID: 19393597
[TBL] [Abstract][Full Text] [Related]
8. What is the best protocol of single-agent methotrexate chemotherapy in nonmetastatic or low-risk metastatic gestational trophoblastic tumors? A review of the evidence.
Foulmann K; Guastalla JP; Caminet N; Trillet-Lenoir V; Raudrant D; Golfier F; Schott AM
Gynecol Oncol; 2006 Jul; 102(1):103-10. PubMed ID: 16624388
[TBL] [Abstract][Full Text] [Related]
9. Treatment for low-risk gestational trophoblastic disease: comparison of single-agent methotrexate, dactinomycin and combination regimens.
AbrĂ£o RA; de Andrade JM; Tiezzi DG; Marana HR; Candido dos Reis FJ; Clagnan WS
Gynecol Oncol; 2008 Jan; 108(1):149-53. PubMed ID: 17931696
[TBL] [Abstract][Full Text] [Related]
10. Management of low-risk gestational trophoblastic neoplasia in indigent women.
Schorge JO; Lea JS; Farrar DF; King MR; Coleman RL; Miller DS
J Reprod Med; 2003 Oct; 48(10):780-4. PubMed ID: 14628732
[TBL] [Abstract][Full Text] [Related]
11. Comparison of pulse methotrexate and pulse dactinomycin in the treatment of low-risk gestational trophoblastic neoplasia.
Gilani MM; Yarandi F; Eftekhar Z; Hanjani P
Aust N Z J Obstet Gynaecol; 2005 Apr; 45(2):161-4. PubMed ID: 15760322
[TBL] [Abstract][Full Text] [Related]
12. Methotrexate, bleomycin, and Etoposide in the treatment of gestational trophoblastic neoplasia.
Ngan HY; Tam KF; Lam KW; Chan KK
Obstet Gynecol; 2006 May; 107(5):1012-7. PubMed ID: 16648404
[TBL] [Abstract][Full Text] [Related]
13. Methotrexate on a 21-day cycle for low-risk gestational trophoblastic neoplasia.
Diaz J; Thomas MB; Paz-Pabon C; Hernandez E
J Reprod Med; 2012; 57(9-10):411-4. PubMed ID: 23091988
[TBL] [Abstract][Full Text] [Related]
14. Relapse rate of patients with low-risk gestational trophoblastic tumor initially treated with single-agent chemotherapy.
Matsui H; Suzuka K; Yamazawa K; Tanaka N; Mitsuhashi A; Seki K; Sekiya S
Gynecol Oncol; 2005 Mar; 96(3):616-20. PubMed ID: 15721402
[TBL] [Abstract][Full Text] [Related]
15. Single-agent pulse dactinomycin has only modest activity for methotrexate-resistant gestational trophoblastic neoplasia.
Chen LM; Lengyel ER; Bethan Powell C
Gynecol Oncol; 2004 Jul; 94(1):204-7. PubMed ID: 15262143
[TBL] [Abstract][Full Text] [Related]
16. Gestational trophoblastic neoplasia management: an update.
Ngan S; Seckl MJ
Curr Opin Oncol; 2007 Sep; 19(5):486-91. PubMed ID: 17762576
[TBL] [Abstract][Full Text] [Related]
17. Evaluating methotrexate treatment in patients with low-risk postmolar gestational trophoblastic neoplasia.
Growdon WB; Wolfberg AJ; Goldstein DP; Feltmate CM; Chinchilla ME; Lieberman ES; Berkowitz RS
Gynecol Oncol; 2009 Feb; 112(2):353-7. PubMed ID: 19059633
[TBL] [Abstract][Full Text] [Related]
18. Methotrexate monotherapy for high-risk gestational trophoblastic neoplasia after therapy with etoposide, methotrexate, and dactinomycin: a case report.
Taran A; Ignatov A; Smith B; Bischoff J; Costa SD
Am J Obstet Gynecol; 2008 Nov; 199(5):e6-8. PubMed ID: 18984073
[TBL] [Abstract][Full Text] [Related]
19. Management of patients with metastatic gestational trophoblastic tumor.
Ghaemmaghami F; Behtash N; Soleimani K; Hanjani P
Gynecol Oncol; 2004 Jul; 94(1):187-90. PubMed ID: 15262140
[TBL] [Abstract][Full Text] [Related]
20. Phase II trial of pulse dactinomycin as salvage therapy for failed low-risk gestational trophoblastic neoplasia: a Gynecologic Oncology Group study.
Covens A; Filiaci VL; Burger RA; Osborne R; Chen MD;
Cancer; 2006 Sep; 107(6):1280-6. PubMed ID: 16900525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]